Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool

Abstract

Introduction Investigation of the molecular basis of inherited bleeding disorders (IBD) is mostly performed with gene panel sequencing. However, the continuous discovery of new related genes underlies the limitation of this approach. This study aimed to identify genetic variants responsible for IBD in pediatric patients using whole-exome sequencing (WES), and to provide a detailed description and reclassification of candidate variants.

Material and Methods WES was performed for 18 pediatric patients, and variants were filtered using a first-line list of 290 genes. Variant prioritization was discussed in a multidisciplinary team based on genotype-phenotype correlation, and segregation studies were performed with available family members.

Results The study identified 22 candidate variants in 17 out of 18 patients (94%). Eleven patients had complete genotype-phenotype correlation, resulting in a diagnostic yield of 61%, 5 (28%) were classified as partially solved, and 2 (11%) remained unsolved. Variants were identified in platelet (ACTN1, ANKRD26, CYCS, GATA1, GFI1B, ITGA2, NBEAL2, RUNX1, SRC, TUBB1), bleeding (APOLD1), and coagulation (F7, F8, F11, VWF) genes. Notably, 9 out of 22 (41%) variants were previously unreported. Variant pathogenicity was assessed according to the American College of Medical Genetics and Genomics guidelines and reclassification of three variants based on family segregation evidence, resulting in the identification of 10 pathogenic or likely pathogenic variants, 6 variants of uncertain significance, and 6 benign or likely benign variants.

Conclusion This study demonstrated the high potential of WES in identifying rare molecular defects causing IBD in pediatric patients, improving their management, prognosis, and treatment, particularly for patients at risk of malignancy and/or bleeding due to invasive procedures.

Keywords

whole-exome sequencing - next-generation sequencing - inherited bleeding disorders - genotype-phenotype correlation - thrombocytopenia - children cohort

Publication History

Received: 07 June 2023

Accepted: 30 November 2023

Article published online:
29 December 2023

• References

• 1 Castaman G, Linari S. Diagnosis and treatment of von Willebrand disease and rare bleeding disorders. J Clin Med 2017; 6 (04) 45
• 2 Haley KM. Platelet disorders. Pediatr Rev 2020; 41 (05) 224-235
• 3 Jackson SC, Odiaman L, Card RT, van der Bom JG, Poon MC. Suspected collagen disorders in the bleeding disorder clinic: a case-control study. Haemophilia 2013; 19 (02) 246-250
• 4 Malfait F, De Paepe A. Bleeding in the heritable connective tissue disorders: mechanisms, diagnosis and treatment. Blood Rev 2009; 23 (05) 191-197
• 5 Sánchez-Guiu I, Antón AI, Padilla J. et al. Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study. Orphanet J Rare Dis 2014; 9: 213
• 6 O'Brien SH. An update on pediatric bleeding disorders: bleeding scores, benign joint hypermobility, and platelet function testing in the evaluation of the child with bleeding symptoms. Am J Hematol 2012; 87 (Suppl. 01) S40-S44
• 7 Israels SJ, Kahr WH, Blanchette VS, Luban NL, Rivard GE, Rand ML. Platelet disorders in children: a diagnostic approach. Pediatr Blood Cancer 2011; 56 (06) 975-983
• 8 Andersson NG, Rossing M, Fager Ferrari M. et al. Genetic screening of children with suspected inherited bleeding disorders. Haemophilia 2020; 26 (02) 314-324
• 9 Monteferrario D, Bolar NA, Marneth AE. et al. A dominant-negative GFI1B mutation in the gray platelet syndrome. N Engl J Med 2014; 370 (03) 245-253
• 10 Noetzli L, Lo RW, Lee-Sherick AB. et al. Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet 2015; 47 (05) 535-538
• 11 Kunishima S, Okuno Y, Yoshida K. et al. ACTN1 mutations cause congenital macrothrombocytopenia. Am J Hum Genet 2013; 92 (03) 431-438
• 12 Turro E, Greene D, Wijgaerts A. et al; BRIDGE-BPD Consortium. A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies. Sci Transl Med 2016; 8 (328) 328ra30
• 13 Cortini F, Villa C, Marinelli B, Combi R, Pesatori AC, Bassotti A. Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing. Arch Dermatol Res 2019; 311 (04) 265-275
• 14 Simeoni I, Stephens JC, Hu F. et al. A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood 2016; 127 (23) 2791-2803
• 15 Gresele P, Falcinelli E, Bury L. Laboratory diagnosis of clinically relevant platelet function disorders. Int J Lab Hematol 2018; 40 (Suppl. 01) 34-45
• 16 Bastida JM, Lozano ML, Benito R. et al. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica 2018; 103 (01) 148-162
• 17 Downes K, Megy K, Duarte D. et al; NIHR BioResource. Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders. Blood 2019; 134 (23) 2082-2091
• 18 Van Laer C, Jacquemin M, Baert S. et al. Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience. J Thromb Haemost 2023; 21 (04) 887-895
• 19 Stevenson WS, Morel-Kopp MC, Chen Q. et al. GFI1B mutation causes a bleeding disorder with abnormal platelet function. J Thromb Haemost 2013; 11 (11) 2039-2047
• 20 Levin C, Koren A, Pretorius E. et al. Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small-platelet thrombocytopenia. J Thromb Haemost 2015; 13 (07) 1285-1292
• 21 Gresele P. Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13 (02) 314-322
• 22 Ver Donck F, Labarque V, Freson K. Hemostatic phenotypes and genetic disorders. Res Pract Thromb Haemost 2021; 5 (08) e12637
• 23 Saes JL, Simons A, de Munnik SA. et al. Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis. Haemophilia 2019; 25 (01) 127-135
• 24 Leinøe E, Zetterberg E, Kinalis S. et al. Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, Scandinavia. Br J Haematol 2017; 179 (02) 308-322
• 25 Stasi R, Newland AC. ITP: a historical perspective. Br J Haematol 2011; 153 (04) 437-450
• 26 Kopanos C, Tsiolkas V, Kouris A. et al. VarSome: the human genomic variant search engine. Bioinformatics 2019; 35 (11) 1978-1980
• 27 Rodeghiero F, Tosetto A, Abshire T. et al; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC Bleeding Assessment Tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8 (09) 2063-2065
• 28 Jain S, Zhang S, Acosta M, Malone K, Kouides P, Zia A. Prospective evaluation of ISTH-BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic. J Thromb Haemost 2020; 18 (10) 2542-2550
• 29 Gilad O, Dgany O, Noy-Lotan S. et al. Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children. Haematologica 2022; 107 (09) 2081-2095
• 30 Hasegawa A, Shimizu R. GATA1 activity governed by configurations of cis-acting elements. Front Oncol 2017; 6: 269
• 31 Thivakaran A, Botezatu L, Hönes JM. et al. Gfi1b: a key player in the genesis and maintenance of acute myeloid leukemia and myelodysplastic syndrome. Haematologica 2018; 103 (04) 614-625
• 32 Möröy T, Vassen L, Wilkes B, Khandanpour C. From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation. Blood 2015; 126 (24) 2561-2569
• 33 Matsumura T, Nakamura-Ishizu A, Takaoka K. et al. TUBB1 dysfunction in inherited thrombocytopenia causes genome instability. Br J Haematol 2019; 185 (05) 888-902
• 34 Kunishima S, Nishimura S, Suzuki H, Imaizumi M, Saito H. TUBB1 mutation disrupting microtubule assembly impairs proplatelet formation and results in congenital macrothrombocytopenia. Eur J Haematol 2014; 92 (04) 276-282
• 35 Noris P, Perrotta S, Seri M. et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood 2011; 117 (24) 6673-6680
• 36 Stritt S, Nurden P, Nurden AT. et al. APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis. Haematologica 2023; 108 (03) 772-784
• 37 Noris P, Guidetti GF, Conti V. et al. Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia. Thromb Haemost 2006; 95 (03) 483-489
• 38 Kazandzhieva K, Mammadova-Bach E, Dietrich A, Gudermann T, Braun A. TRP channel function in platelets and megakaryocytes: basic mechanisms and pathophysiological impact. Pharmacol Ther 2022; 237: 108164
• 39 van Galen KPM, d'Oiron R, James P. et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH. J Thromb Haemost 2021; 19 (08) 1883-1887
• 40 Gotovac Jerčić K, Blažeković A, Hančević M, Bilić E, Borovečki F. Congenital factor XI deficiency caused by a novel F11 missense variant: a case report. Croat Med J 2020; 61 (01) 62-65
• 41 Owaidah T, Saleh M, Baz B. et al. Molecular yield of targeted sequencing for Glanzmann thrombasthenia patients. NPJ Genom Med 2019; 4: 4
• 42 Ver Donck F, Downes K, Freson K. Strengths and limitations of high-throughput sequencing for the diagnosis of inherited bleeding and platelet disorders. J Thromb Haemost 2020; 18 (08) 1839-1845
• 43 Rabbolini DJ, Morel-Kopp MC, Ward CM, Stevenson WS. GFI1B variants associated with thrombocytopenia. Platelets 2017; 28 (05) 525-527
• 44 Turro E, Astle WJ, Megy K. et al; NIHR BioResource for the 100,000 Genomes Project. Whole-genome sequencing of patients with rare diseases in a national health system. Nature 2020; 583 (7814) 96-102
• 45 Sullivan MJ, Palmer EL, Botero JP. ANKRD26-related thrombocytopenia and predisposition to myeloid neoplasms. Curr Hematol Malig Rep 2022; 17 (05) 105-112
• 46 Zhao L, Liu H, Yuan X, Gao K, Duan J. Comparative study of whole exome sequencing-based copy number variation detection tools. BMC Bioinformatics 2020; 21 (01) 97
• 47 Mantere T, Neveling K, Pebrel-Richard C. et al. Optical genome mapping enables constitutional chromosomal aberration detection. Am J Hum Genet 2021; 108 (08) 1409-1422